Iovance Biotherapeutics
IOVA
IOVA
252 hedge funds and large institutions have $4.58B invested in Iovance Biotherapeutics in 2020 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 83 increasing their positions, 91 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
9% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 91
10% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 51
2% less funds holding
Funds holding: 257 → 252 (-5)
Holders
252
Holding in Top 10
9
Calls
$52.7M
Puts
$26.5M
Top Buyers
| 1 | +$121M | |
| 2 | +$44.7M | |
| 3 | +$25.3M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$25M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$14.4M |
Top Sellers
| 1 | -$56.7M | |
| 2 | -$32.2M | |
| 3 | -$27.2M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$20.8M |
| 5 |
Goldman Sachs
New York
|
-$20.2M |